Abstract 4141966: Myotonic Dystrophy type I (DM1) Impairs Cardiac Bioenergetics and Disrupts Cardiac Mitochondrial Fusion-Fission Dynamics

Background: DM1 is the commonest cause of adult-onset muscular dystrophy, affecting 1-in-2100 people in the U.S. DM1 is a (CTG)n trinucleotide repeat expansion disease in the 3’UTR of the DMPK gene. Once expressed, the repeat RNA form toxic hairpins, which sequester the muscle blind-like (MBNL) family of splicing factors. This induces tissue-wide disruption of alternative splicing events, resulting in DM1 symptoms, including muscle weakness, neurological defects, and cardiomyopathy. Recent reports have demonstrated impaired mitochondrial function in the brain, skeletal muscle, and fibroblast of DM1 patients, these have however, not been reported in the heart, nor have their potential contribution to the pathogenesis of DM1 cardiomyopathy been explored. Methods: Using an inducible, cardiomyocyte-specific DM1 mouse model (aka MHCrtTA:TRE960i), we performed extracellular flux analysis on cardiac mitochondrial fractions obtained from heart tissue of control and DM1 mice. This was accompanied by quantification of ATP production, to determine oxidative phosphorylation (OXPHOS) efficiency. Further, we performed transmission electron microscopy (TEM) and TOM20 immunofluorescence (IF) microscopy to assess the integrity of mitochondrial network in DM1 mice. Finally, we performed gene expression studies to identify mis-splicing events involving mitochondria-related genes and validated these in heart tissues obtained from both DM1 mice and deceased human DM1 subjects. Results: DM1 induced a multi-state increase in cardiac oxygen consumption rate (OCR) which was however accompanied by decreased ATP levels (2.83µM/10µg vs. 2.45µM/10µg, p =0.0079) indicating reduced cardiac OXPHOS efficiency. DM1 also induced a disruption of mitochondria network, with increased mitochondria fragmentation seen on IF microscopy, and expansion of the intermyofibrillar mitochondria compartment seen on TEM. These findings correlated with the mis-splicing of mitochondrial fission factor (MFF), with an increased skipping of Mff exon 6 in DM1 mice (ΔΨ: -16.8%, p =0.0069) and human DM1 heart tissue (ΔΨ: -19%, p <0.01) compared with controls. Interestingly, this resulted in the increased expression of a shortened 29kDa MFF protein isoform in DM1 mice (Δ%29kDa: 47%, p =0.0003) and human (Δ%29kDa: 21.1%, p <0.0001) heart samples relative to controls. Conclusion: DM1 impairs cardiac bioenergetic function potentially through the mis-splicing of critical genes regulating mitochondrial fusion-fission dynamics.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4141966
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4141966: Myotonic Dystrophy type I (DM1) Impairs Cardiac Bioenergetics and Disrupts Cardiac Mitochondrial Fusion-Fission Dynamics

Subhashis Natua, Oluwafolajimi Adesanya, Auinash Kalsotra, Pouya Nabie
Circulation
Genetic Neurodegenerative Diseases
article

Abstract 4141966: Myotonic Dystrophy type I (DM1) Impairs Cardiac Bioenergetics and Disrupts Cardiac Mitochondrial Fusion-Fission Dynamics

Subhashis Natua, Oluwafolajimi Adesanya, Auinash Kalsotra, Pouya Nabie
article en

Abstract

Background: DM1 is the commonest cause of adult-onset muscular dystrophy, affecting 1-in-2100 people in the U.S. DM1 is a (CTG)n trinucleotide repeat expansion disease in the 3’UTR of the DMPK gene. Once expressed, the repeat RNA form toxic hairpins, which sequester the muscle blind-like (MBNL) family of splicing factors. This induces tissue-wide disruption of alternative splicing events, resulting in DM1 symptoms, including muscle weakness, neurological defects, and cardiomyopathy. Recent reports have demonstrated impaired mitochondrial function in the brain, skeletal muscle, and fibroblast of DM1 patients, these have however, not been reported in the heart, nor have their potential contribution to the pathogenesis of DM1 cardiomyopathy been explored. Methods: Using an inducible, cardiomyocyte-specific DM1 mouse model (aka MHCrtTA:TRE960i), we performed extracellular flux analysis on cardiac mitochondrial fractions obtained from heart tissue of control and DM1 mice. This was accompanied by quantification of ATP production, to determine oxidative phosphorylation (OXPHOS) efficiency. Further, we performed transmission electron microscopy (TEM) and TOM20 immunofluorescence (IF) microscopy to assess the integrity of mitochondrial network in DM1 mice. Finally, we performed gene expression studies to identify mis-splicing events involving mitochondria-related genes and validated these in heart tissues obtained from both DM1 mice and deceased human DM1 subjects. Results: DM1 induced a multi-state increase in cardiac oxygen consumption rate (OCR) which was however accompanied by decreased ATP levels (2.83µM/10µg vs. 2.45µM/10µg, p =0.0079) indicating reduced cardiac OXPHOS efficiency. DM1 also induced a disruption of mitochondria network, with increased mitochondria fragmentation seen on IF microscopy, and expansion of the intermyofibrillar mitochondria compartment seen on TEM. These findings correlated with the mis-splicing of mitochondrial fission factor (MFF), with an increased skipping of Mff exon 6 in DM1 mice (ΔΨ: -16.8%, p =0.0069) and human DM1 heart tissue (ΔΨ: -19%, p <0.01) compared with controls. Interestingly, this resulted in the increased expression of a shortened 29kDa MFF protein isoform in DM1 mice (Δ%29kDa: 47%, p =0.0003) and human (Δ%29kDa: 21.1%, p <0.0001) heart samples relative to controls. Conclusion: DM1 impairs cardiac bioenergetic function potentially through the mis-splicing of critical genes regulating mitochondrial fusion-fission dynamics.

CirculationVol. 150(Suppl_1)
University of Illinois Urbana-Champaign (US)
Openalex Percentile: Top 78%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.